Label-Free Array Systems Market To Be Dominated By The Drug Discovery Segment By 2028
Technological advancement
for diagnostics is expected to drive Global Label-Free Array Systems Market in
the forecast period, 2024-2028.
According to TechSci Research report, “Label-Free array systems
market–Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, the
Global Label-Free Array Systems Market is anticipated to grow at a steady rate
in the forecast period, 2024-2028. This can be attributed to the benefits
associated with Label-free array systems such as reliability, rapid delivery,
and accurate result production in comparison of other labelled techniques. Label-free
array systems are biosensors that use various physical and chemical techniques
to detect biomolecular interactions without the need for labels or tags. These
systems have various applications in drug discovery, diagnostics, and
fundamental biological research.
The key component
of label-free array systems is the sensor surface, which is coated with a
functional layer that interacts with the biomolecules of interest. The
interaction between the biomolecules and the sensor surface results in a change
in the physical or chemical properties of the sensor, such as refractive index,
mass, or charge. These changes can be measured and analyzed to determine the
concentration, affinity, kinetics, and specificity of the biomolecular
interaction.
Techniques
such as biochips or microarrays, mass spectroscopy, and other advanced
techniques are utilized for detecting clinical micro-organisms. The
manufacturers are creating specifically imaging biosensors which can be
incorporated into microplates to detect the cell lines, molecules, and proteins.
When a sample containing the target micro-organisms is added to the biochip,
the probes on the surface bind to their complementary targets, resulting in a
detectable signal. Biochips or microarrays can be used for the identification,
quantification, and characterization of clinical micro-organisms, including
bacteria, viruses, and fungi. For instance, microarrays can detect
antibiotic-resistant genes in bacteria, viral RNA in blood samples, and fungal
antigens in serum.
Also, several other advanced techniques have been
developed and utilized for the detection of clinical micro-organisms using
label-free array systems. These techniques such as surface-enhanced Raman spectroscopy (SERS),
electrochemical impedance spectroscopy (EIS), and colorimetry. SERS is a
vibrational spectroscopy technique that can enhance the Raman signal of
molecules on a metallic surface, allowing for the detection of trace amounts of
micro-organisms. EIS is an electrochemical technique that measures the changes
in the impedance of a sensor surface when micro-organisms bind to the
functional layer, enabling their detection. Colorimetry is a simple and
low-cost technique that uses changes in color to detect micro-organisms, such
as bacterial colonies on agar plates. Thus, label-free array systems offer a
promising platform for the rapid and accurate detection of clinical
micro-organisms.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Label-Free array systems Market.”
Label-free
array systems in disease diagnosis is the identification of disease-specific
signatures. These signatures are patterns of biomolecules that are
characteristic of a particular disease or condition. By analyzing the molecular
content of a sample using label-free array systems, researchers can identify
disease-specific signatures that can be used for diagnosis and monitoring. For
example, a label-free array system could be used to identify a unique protein
signature in the blood of patients with Alzheimer's disease, allowing for
earlier detection and improved treatment outcomes.
Additionally,
Label-free array systems can also be used to monitor disease progression in
real-time. By analyzing biomolecules in a sample over time, researchers can
track changes in disease activity and response to treatment. For instance, a
label-free array system could be used to monitor changes in the levels of
specific proteins in the blood of a patient with cancer, allowing clinicians to
adjust treatment strategies as needed. Moreover, the utilization of techniques
such as nanofluidic array, for label free detection of biomolecules is driving
the market growth and is anticipated to fuel in the forecast period.
The key market
players are expanding their portfolio and are thus driving through expanding
the Label-Free array systems via mergers & acquisitions. For instance, In
November 2018, Agilent technologies, Inc took over ACEA Biosciences (ACEA) and
thereby expanded their portfolio segment by including Label-Free array systems.
Based
on type, the market is segmented into surface plasmon
resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others.
The surface plasmon resonance segment is dominating the market in 2022, and is
expected to hold the highest market share in the forecast period. Surface
plasmon resonance is an extensively used technique and is a substitute to
single or dual color labelling techniques. SPR technique is highly utilized in
antigen-antibody reaction in protein microarray, and kinetic analysis.
Based
on the application, the market is segmented into drug discovery,
protein interface analysis, antibody characterization, and others. The drug
discovery application segment dominated in 2022 and is anticipated to do the
same in the forecast period. This is on account of rising use of label-free
array systems in drug discovery, increased Research and development and growing
investment for new drug development in the pharmaceutical &
biotechnological industries. Also, growing applications of label-free array
systems in drug discovery is propelling the market growth.
Major companies operating in the Global Label-Free
Array Systems Market are:
- Illumina,
Inc.
- Thermo
Fisher Scientific, Inc.
- Agilent
Technologies, Inc.
- PerkinElmer,
Inc.
- Merck
KGaA
- Danaher
Corporation
- Bio-Rad
Laboratories, Inc.
- F.
Hoffmann-La Roche AG
- Becton,
Dickinson and Company
- Sartorius
AG
Companies operating in the market are following strategies such as
continuously innovating tools to improve image quality and creating specialized
clinical tools to help the patients see more anatomical detail with greater
certainty, enabling them to provide the best possible patient care, to stay
competitive and have an edge over other players operating in the industry.
Download Free Sample Report
Customers can also request for 10% free
customization on this report.
“North America region is dominating the Label-Free Array
Systems Market in recent years, attributed to the increased research &
development regarding drug discovery and disease diagnosis. Besides, large
number of research centers, diagnostics, and pharmaceutical companies in the
region, rising investment for drug discovery and development is adding to
market growth.” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management consulting firm.
Label-Free Array Systems Market – “Global
Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028,
Segmented By Type (Surface Plasmon Resonance, Bio-layer Interferometry,
Cellular Dielectric Spectroscopy, Others), By Application (Drug Discovery,
Protein Interface Analysis, Antibody Characterization, Others), By End user
(Pharmaceutical and Biotechnology Companies, Academic and Research Institutes,
Contract Research Organizations, Others), By Region and Competition”, has evaluated the future
growth potential of Label-Free array systems market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global Label-Free array systems market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com